CD8A and cancer: It is equally important to recognize that these populations may only arise in cancers that are more localized (e.g., breast cancer, melanoma) rather than systemic (e.g., leukemia or lymphoma) and that the rate of disease progression may play a major role in determining if “memory-like” CD8+ T cells will form.